https://pittplusme.org/study/palmoplantar
Be Seen
STUDY BASICS
Have you been diagnosed with palmoplantar pustulosis (PPP), and have white or yellow pus-filled blisters on the palms of your hands and/or the soles of your feet? You may be able to participate in a study to help researchers test an investigational drug to see if it is well tolerated and effective. This study involves up to 29 visits over approximately 2 years.
STUDY PURPOSE
The aim of the BE SEEN Study is to evaluate the investigational drug bimekizumab in people with PPP. The main study goal is to test the safety (how well it’s tolerated) and efficacy (how well it works) of bimekizumab in patients with PPP and to see what kind of effect it has on the symptoms of PPP.
COULD THIS STUDY BE RIGHT FOR YOU?
- 18 years of age or older
- diagnosed with palmoplantar pustulosis (PPP) for at least 6 months
- currently have active PPP, including pustules on the palms of your hands and the soles of your feet
WHAT PARTICIPANTS CAN EXPECT
In the BE SEEN Study, the study medication is given as subcutaneous (under the skin) injection.
In the main study period, you will be randomly assigned (like drawing a straw) to either the investigational drug, bimekizumab, or a placebo. A placebo looks like bimekizumab but contains no medicinally active ingredients.
For the extension period, all participants will receive bimekizumab. The study team at the study center will explain everything you need to know about this process.
IRB: SSU00315301
- UCB Biopharma SRL - PPP001 / 286480, A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study with Open-label Extension to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants with Palmoplantar Pustulosis (Pro00088439)
MEET THE RESEARCHER
Joe K. Tung
Joe K. Tung, MD, MBA received his undergraduate degree in Molecular Biophysics and Biochemistry at Yale University and his medical degree at Harvard Medical School. He concurrently obtained his Master of Business Administration from Harvard Business School, graduating in the top 5% as a Baker Scholar. Dr. Tung went on to complete his internal medicine intern year at the Brigham and Women's Hospital and his dermatology residency at the University of Pittsburgh Medical Center.
Dr. Tung won a gold medal representing the United States at the 43rd International Chemistry Olympiad. His basic science and clinical research work have resulted in multiple peer-reviewed articles, reviews, textbook chapters, clinical decision support tools, and presentations at national and international meetings. He serves as a reviewer for research journals, as a consultant for pharmaceutical and biotechnology companies, as a principal investigator for global industry-sponsored clinical trials, and as an advisor for multiple healthcare start-ups. In his spare time, Dr. Tung enjoys traveling, playing golf, rock climbing, visiting museums, and attending live sporting events.